3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
9
Squamous Cell Carcinoma of Head and Neck
3
Neoplasms
3
Colorectal Neoplasms
3
Small Cell Lung Carcinoma
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Urinary Bladder Neoplasms
1
Spinocerebellar Degenerations
1
Sarcoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Pancreatic Adenocarcinoma
1
PD-L1-selected Solid Tumors
1
Melanoma
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Chordoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Advanced Solid Malignancies
1
Advanced Rare Malignant Solid Neoplasm
1
Advanced Liver Cancers
1
Interventions
pembrolizumab
4
Proton Therapy
3
toripalimab
1
spartalizumab
1
patritumab deruxtecan
1
osimertinib
1
mirdametinib
1
leronlimab
1
amivantamab
1
Valganciclovir
1
Radiotherapy
1
Paclitaxel
1
Lacteol
1
Interleukin-2
1
Docetaxel
1
Carboplatin
1
Blood Specimen Collection
1
Bevacizumab
1
BGB-283
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumor, Adult
×
Tiragolumab
×
1 year
×
Clear all
No trials found.